Clinical Trials on Lung Mass in Germany

Total 3399 results

Technical University of Munich

Completed

Endoscopic Resection of Gastric Subepithelial Masses, EndoResect Study (EndoResect)

Gastric Subepitelial Mass

Germany
University Hospital Regensburg

Completed

Impact of Surgical Mask, FFP2 Mask and FFP3 Mask (With and Without Exhalation Valve) on Exercise Tolerance and Blood Gas Parameters of Patients With Known Lung Disease and Long-term Oxygen Therapy (FFP-O2)

Face Mask | Longterm Oxygen Therapy

Germany
Universitätsklinikum Hamburg-Eppendorf
Institute of Medical Technology and Intelligent Systems at Hamburg University...

Completed

Prediction of Difficult Mask Ventilation Using 3D-Facescan and Machine Learning (MASCAN)

General Anesthesia | Mask Ventilation

Germany
RWTH Aachen University

Completed

Emergence Times and Airway Reactions in General Laryngeal Mask Airway Anesthesia

Anesthesia With Use of LMA (Laryngeal Mask Airway)

Germany
Goethe University
University Hospital Goettingen

Completed

ASS-Nonresponse Following Cardiac Surgery as Assessed With Multiple Electrode Aggregometry

ASS-Nonresponse

Germany
Ludwig-Maximilians - University of Munich
Allergan

Completed

Dexamethasone-Implant for the Treatment of Macula Edema Due to Irvine Gass Syndrome

Macular Edema | Visual Acuity

Germany
Blueprint Medicines Corporation

Completed

(PROSPECTOR) Screening Study Evaluating the Prevalence of the KIT D816V Mutation in Patients With Systemic Mast Cell Activation

Systemic Mast Cell Activation | KIT D816V Mutation

United States, France, United Kingdom, Italy, Germany, Belgium, Spain, Switzerland
PD Dr. Andreas Strauß
Bayer

Recruiting

Osteoporosis and Haemophilia

Osteoporosis | Haemophilia | Bone Mass

Germany
University Hospital Heidelberg
Institut für Klinische Krebsforschung IKF GmbH am Krankenhaus Nordwest

Completed

Combined PD-1 and CCR5 Inhibition for the Treatment of Refractory Microsatellite Stable mCRC (PICCASSO)

Metastatic Colorectal Cancer | MSS

Germany
Paracelsus Harz Clinic Bad Suderode.

Recruiting

Effects of Inpatient Rehabilitation Measures in Long-COVID-19 Syndrome

Long COVID

Germany
Blueprint Medicines Corporation
Analysis Group, Inc.

Completed

Retrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSM

Mast Cell Leukemia | Aggressive Systemic Mastocytosis | Advanced Systemic Mastocytosis | Systemic Mastocytosis With an Associated Hematological Neoplasm

United States, Austria, Germany, Spain, United Kingdom
Blueprint Medicines Corporation

Active, not recruiting

(PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis

Mast Cell Leukemia | Aggressive Systemic Mastocytosis | Advanced Systemic Mastocytosis | Systemic Mastocytosis With an Associated Hematologic Neoplasm

United States, Canada, United Kingdom, France, Netherlands, Italy, Spain, Austria, Denmark, Germany, Norway, Poland
Blueprint Medicines Corporation

Recruiting

(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

Indolent Systemic Mastocytosis | Monoclonal Mast Cell Activation Syndrome

United States, Spain, Australia, France, Netherlands, Switzerland, Norway, United Kingdom, Austria, Belgium, Germany, Italy, Portugal
University Hospital Tuebingen

Completed

Prospective, Randomised Multicenter Study Comparing the Efficacy of Transbronchial Forceps Biopsy With Cryobiopsy to Diagnose Interstitial Lung Disease. (TRABIS)

Interstitial Lung Disease

Germany
Boehringer Ingelheim

Recruiting

A Study to Test Different Imaging Techniques in Patients With Different Types of Interstitial Lung Disease

Lung Diseases, Interstitial

Germany
AIO-Studien-gGmbH
Bristol-Myers Squibb; Eli Lilly and Company; Merck Sharp & Dohme LLC; Pfizer; Gilead... and other collaborators

Recruiting

Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients (CRISP)

Small-cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage I | Metastatic Non-small Cell Lung Cancer (NSCLC) | Non Small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer Stage II

Germany
University Hospital Heidelberg

Recruiting

Magnetic Resonance Guided Adaptive Stereotactic Body Radiotherapy for Lung Tumors in Ultracentral Location (MAGELLAN)

Lung Cancer

Germany
RWTH Aachen University

Completed

Electrical Impedance Tomography of Lung in Child and Young Age (EIT-Lunge)

Obstructive Lung Diseases

Germany
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., Japan

Completed

Study of Tecemotide (L-BLP25) in Participants With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy

Non-small Cell Lung Cancer

Germany
AIO-Studien-gGmbH
Merck Sharp & Dohme LLC

Terminated

Study of Pembrolizumab Maintenance Following First-Line Platinum Based Chemotherapy in Patients With Metastatic Squamous - Non-Small Cell Lung Cancer (sNSCLC) (PRIMUS)

Metastatic Squamous Non-small Cell Lung Cancer

Germany
Hoffmann-La Roche

Completed

An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer (GERTAC)

Non-Squamous Non-Small Cell Lung Cancer

Germany
University Hospital Heidelberg
German Cancer Research Center; Heidelberg University

Active, not recruiting

Tumor-specific T Cells in Lung Cancer

Non-small Cell Lung Cancer

Germany
University Hospital Heidelberg
German Cancer Research Center; Heidelberg University

Completed

Immune Boost In Non-Small Cell Lung Cancer (RadImmune)

Non-small Cell Lung Cancer

Germany
Wissenschaftliches Institut Bethanien e.V
Roche Pharma AG

Completed

Cardiopulmonary Exercise Testing in Interstitial Lung Disease

Interstitial Lung Disease

Germany
Hoffmann-La Roche

Completed

An Observational Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer

Non-Squamous Non-Small Cell Lung Cancer

Germany
RWTH Aachen University
OBI Medical

Recruiting

Mathematical Arterialisation of Capillary Blood for Blood Gas Analysis in Critical Ill Patients

Lung Diseases

Germany
AIO-Studien-gGmbH
Boehringer Ingelheim

Terminated

Maintaining ERBB Blockade in EGFR-mutated Lung Cancer (MARBLE)

Non-small-cell Lung Cancer With Somatic EGFR Mutations

Germany
AIO-Studien-gGmbH
Merck Sharp & Dohme LLC

Completed

Neoadjuvant Anti PD-1 Immunotherapy in Resectable Non-small Cell Lung Cancer (NEOMUN)

Non-small Cell Lung Cancer (NSCLC)

Germany
Merck KGaA, Darmstadt, Germany

Completed

Trial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-small Cell Lung Cancer (NSCLC) (NEXT)

Non-Small Cell Lung Cancer (NSCLC)

Germany
University Hospital, Essen
Marta Cuyás

Active, not recruiting

Study Comparing Two Different Methods of Cryobiopsy in the Interstitial Lung Diseases

Interstitial Lung Disease

Germany
Wissenschaftliches Institut Bethanien e.V

Completed

Cryobiopsy vs. VATS in Diagnosis of Interstitial Lung Diseases

Interstitial Lung Disease

Germany
Heidelberg University
Lungenfibrose e.V.

Completed

Yoga in Patients With Fibrosing Interstitial Lung Diseases

Idiopathic Pulmonary Fibrosis | Fibrosing Interstitial Lung Diseases

Germany
Broncus Medical Inc
Uptake Medical Technology, Inc.

Unknown

Post-Market Optimization Study of the EMPOWER® RF Catheter to Ablate Soft Tissue Lesions in the Lung

Lung Diseases

Germany
Heidelberg University

Unknown

Biomarker in Lung Diseases

Lung Diseases

Germany
Charite University, Berlin, Germany
Pfizer; Aventis Pharmaceuticals

Unknown

A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage

Small Cell Lung Cancer

Germany
University Hospital, Essen
Epigenomics, Inc

Completed

Methylation Level of SHOX2 in Endobronchial Ultrasound With Real-time Guided Transbronchial Needle Aspiration for Lung Cancer Staging

Lung Cancer With Mediastinal Lymph Node Involvement

Germany
Bristol-Myers Squibb

Completed

Real-Life Study With Nivolumab (BMS-936558) in Advanced NSCLC Patients After Prior Chemotherapy (ENLARGE-Lung)

Non-Small Cell Lung Cancer

Germany
Schön Klinik Berchtesgadener Land

Completed

Effects of an Oxymizer on Endurance Time in Patients With Chronic Lung Diseases

Interstitial Lung Disease | COPD

Germany
PD Dr. med. Wolfgang Schuette
Eli Lilly and Company; Roche Pharma AG

Completed

Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer (65plus)

Non-squamous Non-small Cell Lung Cancer

Germany
Aktion Bronchialkarzinom e.V.

Completed

Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.

Non-Small-Cell Lung Carcinoma

Germany
University Hospital Schleswig-Holstein

Unknown

Regional Lung Opening and Closing Pressures in Patients With Acute Lung Injury

Acute Lung Injury

Germany
Technische Universität Dresden
German Cancer Research Center; National Center for Radiation Research in Oncology...

Recruiting

Proton Therapy to Reduce Acute Normal Tissue Toxicity in Locally Advanced Non-small-cell Lung Cancer (PRONTOX)

Non-Small Cell Lung Cancer

Germany
Heidelberg University

Unknown

EBUS-guided TBNA for Molecular Diagnostic of Mediastinal Lymph Nodes (LN)

Non Small Cell Lung Cancer

Germany
AIO-Studien-gGmbH
AstraZeneca

Terminated

Induction Therapy With Intercalated Tyrosine Kinase Inhibitor (TKI) and Chemotherapy in NSCLC With Activating Epidermal Growth Factor Receptor (EGFR) Mutation in Stages II-IIIB (NeoIntercal)

NSCLC | Non-squamous Non-small Cell Lung Cancer Stage II | Non-squamous Non-small Cell Lung Cancer Stage IIIA | Non-squamous Non-small Cell Lung Cancer Stage IIIB | Activating EGFR Mutation

Germany
Bristol-Myers Squibb

Recruiting

A Study in Participants With First-Line Nivolumab Plus Ipilimumb Therapy Combined With Two Cycles of Chemotherapy for Metastatic Non-Small Cell Lung Cancer (FINN)

Carcinoma, Non-Small-Cell Lung

Germany
Technische Universität Dresden

Completed

Evaluation of Variable Pressure Support Ventilation in the Therapy of Acute Lung Injury (EVA)

Acute Lung Injury

Germany
Technische Universität Dresden

Completed

Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET

Lung Cancer

Germany
German Cancer Research Center
Heidelberg University

Completed

Exercise Study in Patients With Lung Cancer (POSITIVE)

Non Small Cell Lung Cancer

Germany
Hannover Medical School

Unknown

Empowerment of Lung and Heart-lung Transplant Patients

Exercise Training | Lung Transplantation | Psychotherapy | Heart-Lung Transplantation | "Rehabilitation"

Germany
AIO-Studien-gGmbH
AstraZeneca

Recruiting

Radiation During Osimertinib Treatment: a Safety and Efficacy Cohort Study (ROSE)

NSCLC | EGFR Positive Non-small Cell Lung Cancer | Oligoprogression

Germany

Clinical Trials on Lung Mass in Germany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations